INTRODUCTION
============

In pediatric dentistry, mesiodens extraction or surgically assisted orthodontic forced tooth eruption (window opening to induce natural eruption of teeth) is an invasive procedure that requires the precise handling of dental equipment. Therefore, the safe and successful completion of these procedures requires cooperation from patients. General anesthesia is an option for pediatric patients undergoing dental procedures. However, both patients and parents may feel pressure due to the considerable length of time required for the maintenance of venous access and endotracheal intubation, in addition to a prolonged recovery period. Another potential disadvantage to general anesthesia may be the post-procedural discomfort surrounding the throat.

On the other hand, sevoflurane deep sedation allows the maintenance of spontaneous respiration in patients. Endotracheal intubation or the injection of a muscle relaxant is unnecessary, and therefore, the overall duration of anesthesia can be shortened. Moreover, the degree of sedation can be easily manipulated by altering the concentration of sevoflurane, allowing appropriate behavioral management of the patient for the dental treatment. However, the use of a saline solution in cases of bleeding or general washing during the treatment may cause difficulties in the maintenance of spontaneous respiration for patients. LMA can be helpful to resolve this issue by facilitating unobstructed airways. Moreover, LMA enables positive pressure ventilation in cases of apnea by forming a low-pressure seal around the laryngeal inlet.

This study examines the effectiveness of deep sedation with LMA in minor oral surgeries by measuring physiological parameters including the breathing patterns of patients.

MATERIALS AND METHODS
=====================

1. Subjects
-----------

With permission from Dankook University Dental Hospital\'s institutional review board (IRB), this study focused on 11 pediatric dental patients who had undergone dental treatment using LMA under deep sedation with sevoflurane from 2011 to 2015.

Written consent was obtained prior to sedation from all patients, and deep sedation with sevoflurane was induced using LMA after an 8 hour fasting period ([Fig. 1](#F1){ref-type="fig"}). To ensure the patient\'s safety, breathing rate, pulse rate, blood pressure, SpO~2~, and ETCO~2~ levels were observed and recorded.

2. Methods
----------

Through a chart review, the basic characteristics of the patients, treatments performed, the duration of sedation, and LMA sizes were analyzed. In addition, the concentration of sevoflurane inhaled during the treatment, breathing and pulse rates, blood pressure, and SpO~2~ and ETCO~2~ levels were analyzed; minimum, maximum, and average values were calculated. This study followed the categorical normal ranges obtained from the standards of the 5th edition of \"Pediatric and adolescence dentistry\" \[[@B1]\]. Standard readings for the highest and lowest blood pressures in school-aged patients were 90-135 mmHg and 49-70 mmHg, respectively. Other standard measurements such as breathing and pulse rates, SpO~2~ and ETCO~2~ levels ranged from 18-30 times/min, 70-120 beats/min, ≥ 95 mmHg, and 23-51 mmHg respectively.

RESULTS
=======

Most patients were elementary school-aged, with an age distribution range from 6 to 10 years (mean age 8.1 ± 1.4). According to age, the weight distribution ranged from 18 to 53 kg, (mean weight 33 ± 13 kg) ([Table 1](#T1){ref-type="table"}). Mesiodens extraction was performed in 3 patients, and the orthodontic forced tooth eruption (window opening to induce the natural eruption of permanent teeth) was performed in the remaining 8 patients. All 3 mesiodens extraction patients were female, and the group of 8 patients who underwent the window opening procedure included 4 male and 4 female patients. No other underlying or systemic diseases were present in any patients.

The average sedation period was 45 minutes, and the median size of LMA used was 2½. Sevoflurane concentration was at 4% for the initial induction stage, and was maintained at 2% for the remaining treatment period. All patients maintained deep sedation and were unconscious.

The average blood pressure and breathing rates were 98/49 mmHg and 26 times/min. Minimum, maximum, and average values for individual patients are outlined in [Table 2](#T2){ref-type="table"}. Average pulse rates, SpO~2~ and ETCO~2~ levels were 95 beats/min, 99 mmHg, and 41.2 mmHg, respectively. Minimum, maximum, and average values for individual patients are outlined in [Table 3](#T3){ref-type="table"}.

DISCUSSION
==========

Sevoflurane is a volatile inhalation anesthetic, discovered by two scientists -- Ross Terrell and Bernard M. Regan \[[@B2]\]. The discovery and detailed characterization of sevoflurane were first shown in the paper by Wallin et al., 1975 \[[@B3]\]. Sevoflurane was first implemented in clinical settings in Japan in the 1990s.

Deep sedation using sevoflurane was proven to be a safe and effective method for dental treatments, with statistical significance, in two separate studies by Lahoud et al. \[[@B4][@B5]\]. Sevoflurane coupled with N~2~O demonstrated higher success rates for dental treatments, faster recovery time, and reduced side-effects in comparison to cases that used N~2~O alone. The study by Paris et al. compared sedation results between 100 pediatric patients using N~2~O, halothane, and sevoflurane. Significant results from this study indicated shorter induction periods and lower chances of cardiac arrhythmia in sevoflurane-sedated patients compared to halothane-sedated patients \[[@B6]\].

In the study by Lee et al., the authors mentioned that the use of sevoflurane can be an effective alternative to general anesthesia in pediatric dental patients \[[@B7]\]. Supporting evidence indicated the average induction time for sedation was 95 seconds; the average time from the end of sedation, until the patient can open their eyes, was 8 minutes; and the average time until complete recovery occurred was 30 minutes. Therefore, sevoflurane sedation is considered an effective method for pediatric patients with apprehension to dental procedures or uncontrolled behavioral management.

LMA was first discovered in 1981 by a doctor of the Royal London Hospital. Dr. Archie Brain, a British anesthesiologist, improved the Goldman Dental Mask so that it was positioned near the laryngeal inlet instead of the nasal cavity \[[@B8]\].

Unlike the nasal cannula, LMA can minimize gas leakage, allow the maintenance of high level sedation, and provide greater levels of comfort during dental procedures. Moreover, airways are less restricted with LMA in comparison to the nasal cannula. According to the study by Brimacombe and Berry, there are four requirements for the provision of a stable: (1) unobstructed airway, (2) the protection of lungs from aspiration, (3) minimal interference with the visual field for surgery, and (4) low complication rates \[[@B9]\]. Neither endotracheal intubation nor the nasal mask meets the above requirements; LMA provides an alternative with more benefits than risks. The benefits of LMA included an insertion without the use of a laryngoscope or muscle relaxants, and an air-tight seal around the laryngeal inlet. Consequently, the induction time for anesthesia was reduced, and the airways were secured for spontaneous or controlled ventilation. The scavenging of waste gases is possible and is well tolerated by patients during recovery, shortening overall recovery time in patients with short, minor oral surgeries \[[@B10]\].

In addition, the study by Yu and Beirne showed significantly lower rates of laryngospasm and improved neck conditions in patients that used LMA as opposed to endotracheal tubes under general anesthesia \[[@B11]\]. The study by Bennett et al. also demonstrated lower rates of laryngospasm, reduced oxygen saturation levels, lower levels of laryngopharyngeal pain, and less coughing during the recovery in patients treated via LMA as opposed to endotracheal tubes \[[@B12]\]. This was due to the large diameter of LMA, which resulted in reduced resistance from the airways. Therefore, spontaneous respiration was easier, and the degree of airway security was comparable to endotracheal intubation but showed lower complication rates. Since the patient was under spontaneous respiration, there was a risk for respiratory acidosis as ETCO~2~ levels increase with reduced respiration volume. However, in most cases, respiratory acidosis did not induce any severe problems.

Typically, LMA allows lighter anesthesia and faster recovery, and is easier to implement than endotracheal intubation. According to the study by Morse et al., short and simple training is sufficient to provide the fast and effective insertion of LMA. The importance is emphasized in cases which endotracheal intubation is not feasible \[[@B13]\].

Throughout the treatment procedures performed in this study, all physiological parameters were stable within the normal hemodynamic ranges for all 11 patients who underwent dental treatment under deep sevoflurane sedation using LMA. In addition, sedation was stably maintained throughout the entire procedure in all patients.

CONCLUSIONS
===========

Deep sedation with sevoflurane is a more effective, practical, and safe method in comparison to other sedation methods that use N~2~O or a combination of N~2~O and halothane. The rate of successful treatments was higher, in addition to faster recovery rates and the reduction of side-effects. Therefore, sevoflurane sedation may be an effective alternative to general anesthesia.

LMA may minimize gas leakage, maintain high levels of sedation, and provide comfort for patients with easier airway securing. In addition, in comparison to endotracheal intubation, LMA has lower complication rates and maintains the same degree of airway security. The effectiveness of dental treatments is also improved, as LMA allows is conducive to spontaneous respiration in patients under deep sedation. Lastly, both short anesthetic induction times and reduced recovery periods make this method very useful for emergency dental treatments. In conclusion, LMA can be successfully used during deep sedation with sevoflurane for pediatric patients undergoing minor oral surgeries, such as mesiodens extraction or surgically assisted orthodontic forced tooth eruption.

![LMA insertion for deep sevoflurane sedation, used for dental treatment.](jdapm-16-49-g001){#F1}

###### Patient information, dates of visits, and treatment methods

![](jdapm-16-49-i001)

  Name     Date of visit   Age   Gender   Weight (kg)   Treatment
  -------- --------------- ----- -------- ------------- ----------------
  KimOO    2011-11-28      8     M        53            W/O
  KimOO    2013-11-19      8     M        53            W/O
  GilOO    2014-03-18      8     F        30            Mesiodens ext.
  ParkOO   2014-05-13      6     F        18            Mesiodens ext.
  LeeOO    2014-05-21      7     F        25            Mesiodens ext.
  ChoOO    2014-05-27      6     F        21            W/O
  LimOO    2014-08-28      8     F        21            W/O
  KimOO    2014-09-23      10    M        53            W/O
  KimOO    2014-11-06      8     F        21            W/O
  ChoOO    2015-02-25      10    M        39.3          W/O
  ParkOO   2015-03-11      10    F        30            W/O

F: female, M: male, W/O: window opening, ext: extraction.

###### Blood pressure and breathing rates of the patients

![](jdapm-16-49-i002)

  Age   Gender   Blood pressure   Breathing rates                         
  ----- -------- ---------------- ----------------- ----------- ---- ---- ------
  6     F        128/63           100/43            109/48.4    35   26   30.8
  6     F        100/65           71/35             82.5/42     42   29   35.4
  7     F        103/53           89/45             93.8/48.5   24   15   19.4
  8     M        132/75           93/43             107/59      31   24   27.4
  8     M        135/68           112/48            124/48      31   16   26.3
  8     F        119/71           90/52             101.5/57    32   18   28.2
  8     F        106/65           85/40             89.9/49.5   19   14   16.6
  8     F        105/60           80/59             86.1/44.5   39   29   34.8
  10    M        135/66           90/40             98/45       30   26   27.6
  10    M        113/62           86/43             90/47       22   18   20.3
  10    F        145/97           75/35             91/50       24   18   22.7

max: maximum, min: minimum, avg: average, F: female, M: male

###### Pulse rates, SpO~2~ and ETCO~2~ levels of the patients

![](jdapm-16-49-i003)

  Age   Gender   Pulse rate   SpO~2~   ETCO~2~                    
  ----- -------- ------------ -------- --------- ----- ----- ---- ----
  6     F        120          90       99.2      100   99    59   28
  6     F        115          85       87.9      100   100   43   27
  7     F        118          89       93.5      99    99    39   26
  8     M        130          87       108       99    99    64   50
  8     M        118          81       108       100   100   63   26
  8     F        105          82       92.5      100   99    49   35
  8     F        103          65       83        99    99    30   28
  8     F        128          89       98.1      100   99    43   38
  10    M        142          85       104       98    97    58   50
  10    M        87           70       77        100   100   45   34
  10    F        160          75       100       100   98    43   28

max: maximum, min: minimum, avg: average, F: female, M: male
